Cardiac Rhythm Disorder
11
5
5
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 11 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (11)
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
LEAP 2 Chronic EFS
Aveir DR i2i Study
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock
EP Device Registry
AVEIR Remote Care System Non-Significant Risk Study
Patient Preferences for Leadless Pacemakers
Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke
Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices
3T MRI CIED Post-Approval Study